Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27
Sep 20, 2017 12:01 pm UTC| Business
ZUG, Switzerland, Sept. 20, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that...
Benevity Data Shows 2016 Election Cycle Kicked Off Major Shift in Corporate Giving Trends
Sep 20, 2017 12:01 pm UTC| Business
CALGARY, Sept. 20, 2017 -- Benevity, the market leader in workplace giving, volunteering and community investment software, announced today the release of new data showing a significant shift in charitable donation...
Altimmune Announces its Phase 2 Flu Vaccine Trial with NasoVAX Open for Enrollment
Sep 20, 2017 12:01 pm UTC| Business
60 Patients to be enrolledData expected in the first quarter of 2018 GAITHERSBURG, Md., Sept. 20, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that they have been...
Plantronics Launches BackBeat FIT Family to Fuel Your Workout at Any Level
Sep 20, 2017 12:01 pm UTC| Business
SANTA CRUZ, Calif., Sept. 20, 2017 -- Plantronics (NYSE:PLT), a pioneer in audio and wearable technology, today announced the expansion of the company’s sport portfolio with the BackBeat FIT Family, a range of wireless...
Sep 20, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
iBio, Inc. Intellectual Property Update
Sep 20, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 20, 2017 -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, provided an update on recent patents and inventions. ...
MYnd Analytics Appoints Peter Unanue to Board of Directors
Sep 20, 2017 12:01 pm UTC| Business
MISSION VIEJO, Calif., Sept. 20, 2017 -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive medicine company that brings objective physical findings to psychiatric treatment in order to reduce trial and error prescribing...